HEADER MEMBRANE PROTEIN 04-JUL-22 7YDQ TITLE STRUCTURE OF PFNT1(Y190A)-GFP IN COMPLEX WITH GSK4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOSIDE TRANSPORTER 1,GREEN FLUORESCENT PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: PFNT1(Y190A) FUSED WITH GFP THE GFP WAS INSERTED INTO COMPND 7 PFNT1 BETWEEN K370 AND K371 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM 3D7, AEQUOREA VICTORIA; SOURCE 3 ORGANISM_TAXID: 36329, 6100; SOURCE 4 GENE: PF3D7_1347200, GFP; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: IPLB-SF-21-AE(SF9) KEYWDS MALARIA, NUCLEOSIDE TRANSPORTER, GSK4, TRANSPORT PROTEIN, MEMBRANE KEYWDS 2 PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR C.WANG,L.Y.YU,J.L.LI,R.B.REN,D.DENG REVDAT 1 26-APR-23 7YDQ 0 JRNL AUTH C.WANG,L.YU,J.ZHANG,Y.ZHOU,B.SUN,Q.XIAO,M.ZHANG,H.LIU,J.LI, JRNL AUTH 2 J.LI,Y.LUO,J.XU,Z.LIAN,J.LIN,X.WANG,P.ZHANG,L.GUO,R.REN, JRNL AUTH 3 D.DENG JRNL TITL STRUCTURAL BASIS OF THE SUBSTRATE RECOGNITION AND INHIBITION JRNL TITL 2 MECHANISM OF PLASMODIUM FALCIPARUM NUCLEOSIDE TRANSPORTER JRNL TITL 3 PFENT1. JRNL REF NAT COMMUN V. 14 1727 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36977719 JRNL DOI 10.1038/S41467-023-37411-1 REMARK 2 REMARK 2 RESOLUTION. 4.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.040 REMARK 3 NUMBER OF PARTICLES : 329768 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7YDQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1300030537. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : NUCLEOSIDE/NUCLEOBASE REMARK 245 TRANSPORTER FUSION WITH GFP REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 6.00 REMARK 245 SAMPLE DETAILS : THE CDNA OF THE GFP WAS CLONED REMARK 245 INTO PFNT1 BETWEEN K370 AND K371 REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1100.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5245.20 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 ASP A -8 REMARK 465 GLU A -7 REMARK 465 VAL A -6 REMARK 465 ASP A -5 REMARK 465 ALA A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 LYS A 5 REMARK 465 GLU A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 ALA A 10 REMARK 465 TYR A 11 REMARK 465 ALA A 12 REMARK 465 ASP A 13 REMARK 465 ILE A 14 REMARK 465 GLU A 15 REMARK 465 SER A 16 REMARK 465 ARG A 17 REMARK 465 GLY A 18 REMARK 465 ASP A 19 REMARK 465 TYR A 20 REMARK 465 LYS A 21 REMARK 465 ASP A 22 REMARK 465 ASP A 23 REMARK 465 GLY A 24 REMARK 465 LYS A 25 REMARK 465 LYS A 26 REMARK 465 GLY A 27 REMARK 465 SER A 28 REMARK 465 THR A 29 REMARK 465 LYS A 215 REMARK 465 ASN A 216 REMARK 465 ASN A 217 REMARK 465 LYS A 218 REMARK 465 LYS A 219 REMARK 465 ASP A 220 REMARK 465 GLU A 221 REMARK 465 GLU A 222 REMARK 465 ASN A 223 REMARK 465 LYS A 224 REMARK 465 GLU A 225 REMARK 465 ASN A 226 REMARK 465 ASN A 227 REMARK 465 MET A 370A REMARK 465 VAL A 370B REMARK 465 LEU A 602 REMARK 465 GLY A 603 REMARK 465 MET A 604 REMARK 465 ASP A 605 REMARK 465 GLU A 606 REMARK 465 LEU A 607 REMARK 465 TYR A 608 REMARK 465 LYS A 609 REMARK 465 LYS A 610 REMARK 465 ALA A 611 REMARK 465 ASP A 653 REMARK 465 LEU A 654 REMARK 465 PRO A 655 REMARK 465 PRO A 656 REMARK 465 ILE A 657 REMARK 465 ASP A 658 REMARK 465 VAL A 659 REMARK 465 THR A 660 REMARK 465 GLN A 661 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 435 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 60 49.50 36.25 REMARK 500 CYS A 208 49.24 -85.75 REMARK 500 SER A 290 31.62 -94.31 REMARK 500 PHE A 302 34.58 -98.61 REMARK 500 SER A 308 -175.55 -171.21 REMARK 500 ILE A 636 -52.36 -125.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-33756 RELATED DB: EMDB REMARK 900 STRUCTURE OF PFNT1(Y190A)-GFP IN COMPLEX WITH GSK4 DBREF 7YDQ A 1 370 UNP Q8IDM6 Q8IDM6_PLAF7 1 370 DBREF 7YDQ A 372 609 UNP P42212 GFP_AEQVI 2 238 DBREF 7YDQ A 610 661 UNP Q8IDM6 Q8IDM6_PLAF7 371 422 SEQADV 7YDQ MET A -21 UNP Q8IDM6 INITIATING METHIONINE SEQADV 7YDQ HIS A -20 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -19 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -18 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -17 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -16 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -15 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -14 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -13 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -12 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A -11 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ SER A -10 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ GLY A -9 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ ASP A -8 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ GLU A -7 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ VAL A -6 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ ASP A -5 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ ALA A -4 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ GLY A -3 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ SER A -2 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ GLY A -1 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ HIS A 0 UNP Q8IDM6 EXPRESSION TAG SEQADV 7YDQ ALA A 190 UNP Q8IDM6 TYR 190 ENGINEERED MUTATION SEQADV 7YDQ MET A 370A UNP Q8IDM6 LINKER SEQADV 7YDQ VAL A 370B UNP Q8IDM6 LINKER SEQADV 7YDQ LEU A 434 UNP P42212 PHE 64 CONFLICT SEQADV 7YDQ THR A 435 UNP P42212 SER 65 CONFLICT SEQADV 7YDQ ALA A 533 UNP P42212 VAL 163 CONFLICT SEQADV 7YDQ LEU A 602 UNP P42212 HIS 231 CONFLICT SEQRES 1 A 683 MET HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS SER GLY SEQRES 2 A 683 ASP GLU VAL ASP ALA GLY SER GLY HIS MET SER THR GLY SEQRES 3 A 683 LYS GLU SER SER LYS ALA TYR ALA ASP ILE GLU SER ARG SEQRES 4 A 683 GLY ASP TYR LYS ASP ASP GLY LYS LYS GLY SER THR LEU SEQRES 5 A 683 SER SER LYS GLN HIS PHE MET LEU SER LEU THR PHE ILE SEQRES 6 A 683 LEU ILE GLY LEU SER SER LEU ASN VAL TRP ASN THR ALA SEQRES 7 A 683 LEU GLY LEU ASN ILE ASN PHE LYS TYR ASN THR PHE GLN SEQRES 8 A 683 ILE THR GLY LEU VAL CYS SER SER ILE VAL ALA LEU PHE SEQRES 9 A 683 VAL GLU ILE PRO LYS ILE MET LEU PRO PHE LEU LEU GLY SEQRES 10 A 683 GLY LEU SER ILE LEU CYS ALA GLY PHE GLN ILE SER HIS SEQRES 11 A 683 SER PHE PHE THR ASP THR GLN PHE ASP THR TYR CYS LEU SEQRES 12 A 683 VAL ALA PHE ILE VAL ILE GLY VAL VAL ALA GLY LEU ALA SEQRES 13 A 683 GLN THR ILE ALA PHE ASN ILE GLY SER THR MET GLU ASP SEQRES 14 A 683 ASN MET GLY GLY TYR MET SER ALA GLY ILE GLY ILE SER SEQRES 15 A 683 GLY VAL PHE ILE PHE VAL ILE ASN LEU LEU LEU ASP GLN SEQRES 16 A 683 PHE VAL SER PRO GLU LYS HIS TYR GLY VAL ASN LYS ALA SEQRES 17 A 683 LYS LEU LEU ALA LEU TYR ILE ILE CYS GLU LEU CYS LEU SEQRES 18 A 683 ILE LEU ALA ILE VAL PHE CYS VAL CYS ASN LEU ASP LEU SEQRES 19 A 683 THR ASN LYS ASN ASN LYS LYS ASP GLU GLU ASN LYS GLU SEQRES 20 A 683 ASN ASN ALA THR LEU SER TYR MET GLU LEU PHE LYS ASP SEQRES 21 A 683 SER TYR LYS ALA ILE LEU THR MET PHE LEU VAL ASN TRP SEQRES 22 A 683 LEU THR LEU GLN LEU PHE PRO GLY VAL GLY HIS LYS LYS SEQRES 23 A 683 TRP GLN GLU SER HIS ASN ILE SER ASP TYR ASN VAL THR SEQRES 24 A 683 ILE ILE VAL GLY MET PHE GLN VAL PHE ASP PHE LEU SER SEQRES 25 A 683 ARG TYR PRO PRO ASN LEU THR HIS ILE LYS ILE PHE LYS SEQRES 26 A 683 ASN PHE THR PHE SER LEU ASN LYS LEU LEU VAL ALA ASN SEQRES 27 A 683 SER LEU ARG LEU LEU PHE ILE PRO TRP PHE ILE LEU ASN SEQRES 28 A 683 ALA CYS VAL ASP HIS PRO PHE PHE LYS ASN ILE VAL GLN SEQRES 29 A 683 GLN CYS VAL CYS MET ALA MET LEU ALA PHE THR ASN GLY SEQRES 30 A 683 TRP PHE ASN THR VAL PRO PHE LEU VAL PHE VAL LYS GLU SEQRES 31 A 683 LEU LYS MET VAL SER LYS GLY GLU GLU LEU PHE THR GLY SEQRES 32 A 683 VAL VAL PRO ILE LEU VAL GLU LEU ASP GLY ASP VAL ASN SEQRES 33 A 683 GLY HIS LYS PHE SER VAL SER GLY GLU GLY GLU GLY ASP SEQRES 34 A 683 ALA THR TYR GLY LYS LEU THR LEU LYS PHE ILE CYS THR SEQRES 35 A 683 THR GLY LYS LEU PRO VAL PRO TRP PRO THR LEU VAL THR SEQRES 36 A 683 THR LEU THR TYR GLY VAL GLN CYS PHE SER ARG TYR PRO SEQRES 37 A 683 ASP HIS MET LYS GLN HIS ASP PHE PHE LYS SER ALA MET SEQRES 38 A 683 PRO GLU GLY TYR VAL GLN GLU ARG THR ILE PHE PHE LYS SEQRES 39 A 683 ASP ASP GLY ASN TYR LYS THR ARG ALA GLU VAL LYS PHE SEQRES 40 A 683 GLU GLY ASP THR LEU VAL ASN ARG ILE GLU LEU LYS GLY SEQRES 41 A 683 ILE ASP PHE LYS GLU ASP GLY ASN ILE LEU GLY HIS LYS SEQRES 42 A 683 LEU GLU TYR ASN TYR ASN SER HIS ASN VAL TYR ILE MET SEQRES 43 A 683 ALA ASP LYS GLN LYS ASN GLY ILE LYS ALA ASN PHE LYS SEQRES 44 A 683 ILE ARG HIS ASN ILE GLU ASP GLY SER VAL GLN LEU ALA SEQRES 45 A 683 ASP HIS TYR GLN GLN ASN THR PRO ILE GLY ASP GLY PRO SEQRES 46 A 683 VAL LEU LEU PRO ASP ASN HIS TYR LEU SER THR GLN SER SEQRES 47 A 683 ALA LEU SER LYS ASP PRO ASN GLU LYS ARG ASP HIS MET SEQRES 48 A 683 VAL LEU LEU GLU PHE VAL THR ALA ALA GLY ILE THR LEU SEQRES 49 A 683 GLY MET ASP GLU LEU TYR LYS LYS ALA LYS LYS LYS LYS SEQRES 50 A 683 GLU ILE GLU ILE ILE SER THR PHE LEU VAL ILE ALA MET SEQRES 51 A 683 PHE VAL GLY LEU PHE CYS GLY ILE TRP THR THR TYR ILE SEQRES 52 A 683 TYR ASN LEU PHE ASN ILE VAL LEU PRO LYS PRO ASP LEU SEQRES 53 A 683 PRO PRO ILE ASP VAL THR GLN HET IRX A 701 25 HETNAM IRX 5-METHYL-N-[2-(2-OXIDANYLIDENEAZEPAN-1-YL)ETHYL]-2- HETNAM 2 IRX PHENYL-1,3-OXAZOLE-4-CARBOXAMIDE FORMUL 2 IRX C19 H23 N3 O3 HELIX 1 AA1 SER A 31 GLY A 58 1 28 HELIX 2 AA2 ASN A 62 VAL A 83 1 22 HELIX 3 AA3 MET A 89 PHE A 111 1 23 HELIX 4 AA4 THR A 112 MET A 145 1 34 HELIX 5 AA5 MET A 149 GLN A 173 1 25 HELIX 6 AA6 LYS A 185 CYS A 206 1 22 HELIX 7 AA7 TYR A 232 SER A 239 1 8 HELIX 8 AA8 ALA A 242 VAL A 249 1 8 HELIX 9 AA9 VAL A 249 PHE A 257 1 9 HELIX 10 AB1 HIS A 262 ASN A 270 1 9 HELIX 11 AB2 SER A 272 SER A 290 1 19 HELIX 12 AB3 LEU A 309 ASN A 316 1 8 HELIX 13 AB4 SER A 317 LEU A 320 5 4 HELIX 14 AB5 LEU A 321 VAL A 332 1 12 HELIX 15 AB6 HIS A 334 LYS A 338 5 5 HELIX 16 AB7 ASN A 339 GLY A 355 1 17 HELIX 17 AB8 VAL A 360 PHE A 365 1 6 HELIX 18 AB9 GLY A 374 THR A 379 5 6 HELIX 19 AC1 PRO A 426 THR A 435 1 10 HELIX 20 AC2 MET A 448 ASP A 452 5 5 HELIX 21 AC3 PHE A 453 GLY A 461 1 9 HELIX 22 AC4 LYS A 613 GLY A 635 1 23 HELIX 23 AC5 ILE A 636 LEU A 644 5 9 SHEET 1 AA112 VAL A 382 VAL A 392 0 SHEET 2 AA112 HIS A 395 ASP A 406 -1 O GLY A 401 N VAL A 386 SHEET 3 AA112 LYS A 411 CYS A 418 -1 O ILE A 417 N SER A 400 SHEET 4 AA112 HIS A 587 ALA A 597 -1 O MET A 588 N PHE A 416 SHEET 5 AA112 HIS A 569 SER A 578 -1 N SER A 572 O THR A 595 SHEET 6 AA112 SER A 517 ASP A 525 -1 N HIS A 518 O THR A 573 SHEET 7 AA112 GLY A 530 ASN A 540 -1 O GLY A 530 N ASP A 525 SHEET 8 AA112 VAL A 546 PRO A 557 -1 O GLN A 553 N ALA A 533 SHEET 9 AA112 TYR A 462 PHE A 470 -1 N VAL A 463 O THR A 556 SHEET 10 AA112 ASN A 475 GLU A 485 -1 O TYR A 476 N ILE A 468 SHEET 11 AA112 THR A 488 ILE A 498 -1 O THR A 488 N GLU A 485 SHEET 12 AA112 VAL A 382 VAL A 392 1 N ASP A 391 O GLY A 497 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000